Independent Advisor Alliance

Position in CRSP — CRISPR Therapeutics AG

CIK 1696899 CHARLOTTE, NC

Position in CRSP

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$376,135

-$7,830 QoQ

Shares Held

7,907

+8.0% QoQ

Ownership

0.008%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2021

14 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Independent Advisor Alliance holds $6,039,391 across 21 Biotechnology names. CRSP ranks #7 (6.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	3,267	$1,458,846
2	ARQT	Arcutis Biotherapeutics, Inc.	31,597	$744,424
3	REGN	Regeneron Pharmaceuticals, Inc.	725	$560,163
4	ALNY	Alnylam Pharmaceuticals, Inc.	1,602	$530,052
5	ABSI	Absci Corp	153,855	$461,565
6	INCY	Incyte Corp	4,794	$451,211
7	CRSP	CRISPR Therapeutics AG This page	7,907	$376,135
8	GPCR	Structure Therapeutics Inc.	7,444	$358,800

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$376,135	7,907	+8.0%	Shares	Sole	2026-05-12
2025-12-31	$383,965	7,322	-1.6%	Shares	Sole	2026-02-04
2025-09-30	$482,186	7,440	-3.5%	Shares	Sole	2025-11-04
2025-06-30	$374,868	7,707	-3.0%	Shares	Sole	2025-08-11
2025-03-31	$270,470	7,948	+2.1%	Shares	Sole	2025-05-12
2024-12-31	$306,259	7,781	+0.8%	Shares	Sole	2025-02-07
2024-09-30	$362,638	7,719	+29.2%	Shares	Sole	2024-11-13
2024-06-30	$322,655	5,974	+1.4%	Shares	Sole	2024-08-12
2024-03-31	$401,735	5,894	+9.9%	Shares	Sole	2024-05-08
2023-12-31	$335,661	5,362	-64.9%	Shares	Sole	2024-02-08
2023-09-30	$692,469	15,256	+327.2%	Shares	Sole	2023-10-24
2023-06-30	$200,475	3,571	-7.1%	Shares	Sole	2023-07-28
2022-03-31	$241,162	3,842	+35.7%	Shares	Sole	2022-05-06
2021-12-31	$214,533	2,831	—	Shares	Sole	2022-02-11
No filing history on record for this holder in this stock.